TBI failed in my opinion due to dose rate not well understood.
NEU has a completely different and better understanding of the drug(s) now as evidenced with the success of Daybue.
The lack of TH due to Acadia running phase 3 is obvious as we piggy backed the analysis that was already done.
Here we have the results in, therefore NEU need time to analyze and formulate a market announcement.
This is the moment we have all been waiting for. The TH dies not change the insights NEU have seen from the unblinded trial.
I would be extremely surprised to see bad news but in saying that it’s still possible.
Thankfully the TH now allows me ti get done work done, rather than constantly checking the share price,
Good luck everyone
Ann: Trading Halt, page-66
-
- There are more pages in this discussion • 250 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$20.52 |
Change
0.660(3.32%) |
Mkt cap ! $2.622B | |||
| Open | High | Low | Value | Volume |
| $20.00 | $20.66 | $19.94 | $6.431M | 315.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1024 | $20.52 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $20.53 | 285 | 1 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| NEU (ASX) Chart |